Lamellar ichthyosis is a rare genetic skin condition characterized by thick, dry scales covering the entire body. The scales caused by excessive keratin buildup are usually dark gray or brown in color. It results in dry, itchy skin that cracks and bleeds easily. There is no permanent cure for lamellar ichthyosis and treatment mainly involves moisturizing the skin regularly. The global lamellar ichthyosis market is primarily driven by the increasing cases of rare skin diseases and growing awareness about their diagnosis and management. Various non-profit organizations are actively working to spread awareness about rare diseases like lamellar ichthyosis and their available treatment options.
The Global Lamellar Ichthyosis Market is estimated to be valued at USD 5.30 Billion in 2024 and is expected to reach USD 7.21 Billion by 2031, growing at a compound annual growth rate (CAGR) of 4.46% from 2024 to 2031.
Key players operating in the lamellar ichthyosis market are CELGENE CORPORATION, ALLERGAN, NOVARTIS AG.
The demand for Lamellar Ichthyosis Market is growing primarily due to the rising incidence of rare genetic skin disorders globally. As per data, around 1 in every 1,00,000 newborns worldwide are diagnosed with lamellar ichthyosis each year.
Major companies are increasingly investing in R&D to develop more effective topical moisturizers, oral medications and surgical procedures to treat lamellar ichthyosis. For example, Allergan is developing a gene therapy approach aimed at correcting the underlying genetic defects causing lamellar ichthyosis.
Market Trends
Increased Focus on Gene Therapy - Gene therapy is emerging as a promising treatment option for several inherited disorders including lamellar ichthyosis. Several biotechs are investigating gene transfer methods to introduce functioning copies of defective genes into the skin cells of patients through viral vectors.
Rising Popularity of Tele-dermatology - Due to the coronavirus pandemic, tele-dermatology services that allow remote monitoring and consultation for rare skin conditions like lamellar ichthyosis have gained significant popularity. This trend is expected to continue in the post-pandemic period.
Market Opportunities
Asia Pacific Represents Major Growth Prospects - Asia Pacific region, especially India and China are projected to provide lucrative opportunities for players operating in the lamellar ichthyosis market. This is attributed to improving access to healthcare and increasing healthcare expenditures in emerging Asian countries.
Expansion of Early Diagnosis Measures- Significant market opportunities exist for companies offering diagnostic tests and screening programs for early diagnosis of lamellar ichthyosis. This can facilitate timely management and lead to better clinical outcomes.
Impact of COVID-19 on Lamellar Ichthyosis Market Growth
The COVID-19 pandemic had a notable impact on the growth of the lamellar ichthyosis market. In the pre-COVID era, the market was growing steadily at a CAGR of 4.4% driven by increasing awareness, diagnosis rates, and availability of treatment options. However, during the pandemic, the market experienced a temporary slump as dermatology practices shut down or operated on restricted hours.
However, the market is recuperating in the post-COVID period as restrictions are being lifted. Teleconsultations have emerged as an important tool to continue serving patients in a safe manner. Drug manufacturers are scaling up production to meet the pent-up demand. The focus is now on enhancing diagnosis through extensive outreach programs. Government initiatives are promoting online doctor consultations and home delivery of medicines. Market players are exploring partnerships with telehealth platforms.
Geographical Regions with High Lamellar Ichthyosis Market Value
North America currently dominates the global lamellar ichthyosis market in terms of value, attributed to factors such as well-established healthcare systems, high diagnosis rates, widespread health insurance, and rapid uptake of new treatment options. The United States represents the major revenue generator within the region. Besides North America, Western Europe is another lucrative market supported by rising per capita healthcare spends and fast regulatory approvals of novel drugs.
Fastest Growing Regional Market for Lamellar Ichthyosis
The Asia Pacific region, ex-Japan and China specifically, is poised to witness the highest growth in the lamellar ichthyosis market over the forecast period. This is attributed to rising medical tourism, growing penetration of health insurance, favorable government policies supporting healthcare modernization, increasing investments by multinational pharma players, and greater awareness about rare skin disorders. Heightened trade relationships are further improving the availability of advanced treatments in developing Asian nations at affordable rates.
Get more insights on: Lamellar Ichthyosis Market
Get this Report in Japanese Language: ラメラ魚鱗癬市場
Get this Report in Korean Language: 라멜라 한포진 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)